Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000429457 | SCV000522587 | likely benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000429457 | SCV003732801 | uncertain significance | not specified | 2022-11-01 | criteria provided, single submitter | clinical testing | The c.6643C>G (p.P2215A) alteration is located in exon 20 (coding exon 20) of the RANBP2 gene. This alteration results from a C to G substitution at nucleotide position 6643, causing the proline (P) at amino acid position 2215 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003437178 | SCV004148988 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | RANBP2: BP4 |